Physician profile
Clarissa E David
NPI 1447970678
$1,891.65
in general payments reported to CMS, 2019-2025
19 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $548 · 2024: $902 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,891.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $459.42 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $303.95 | 2023-2025 | |
| Amgen INC. | $280.79 | 2023-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $145.01 | 2023-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.10 | 2024 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $102.12 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $87.52 | 2024-2025 | |
| Inspire Medical Systems, INC. | $55.71 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $51.88 | 2023-2024 | Amvuttra |
| Kestra Medical Technology Services, INC. | $48.18 | 2025 | Assure Wcd |
| Irhythm Technologies, INC. | $36.07 | 2024 | Zio Xt Patch, Zio Monitor |
| Altathera Pharmaceuticals LLC | $29.54 | 2025 | Sotalol Hydrochloride |
| Actelion Pharmaceuticals US, INC. | $24.77 | 2023 | Uptravi, Opsumit |
| Abiomed | $22.62 | 2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $22.55 | 2024 | Farxiga |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $22.31 | 2023 | Arcalyst |
| Recor Medical INC | $22.11 | 2025 | Paradise Ultrasound Renal Denervation System |
| Merck Sharp & Dohme LLC | $21.93 | 2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $13.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clarissa David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.